Clostridium Perfringens Types C&D ToxoidThis page contains information on Clostridium Perfringens Types C&D Toxoid for veterinary use.
The information provided typically includes the following:
- Clostridium Perfringens Types C&D Toxoid Indications
- Warnings and cautions for Clostridium Perfringens Types C&D Toxoid
- Direction and dosage information for Clostridium Perfringens Types C&D Toxoid
Clostridium Perfringens Types C&D ToxoidThis treatment applies to the following species:
Clostridium Perfringens Types C & D Toxoid
U.S. Vet. Lic. No.: 188
Contents: Purified formalin detoxified filtrates of highly toxic cultures of Clostridium perfringens types C and D micro-organisms.
Contains thimerosal as a preservative.
Clostridium Perfringens Types C&D Toxoid Indications
For the vaccination of healthy cattle, sheep, and goats as an aid in the prevention of enterotoxemia caused by Clostridium perfringens types C and D. For the vaccination of healthy swine as an aid in the prevention of enterotoxemia caused by Clostridium perfringens type C.
Dosage and AdministrationInject 2 mL subcutaneously or intramuscularly. Repeat the full dose in 3 to 4 weeks.
Precaution(s): Shake well. Each dose must have a proportionate share of the precipitate for proper responses. Use entire contents when first opened.
Store in dark at 2° to 7°C. Do not freeze.
Caution(s): Anaphylactoid reaction sometimes follows administration of products of this nature. If noted, administer adrenalin or equivalent.
For veterinary use only.
Warning(s): Do not vaccinate within 21 days before slaughter.
Presentation: 10 dose (20 mL), 50 dose (100 mL), and 125 dose (250 mL) vials.
NAC No.: 14250081
4950 YORK STREET, P.O. BOX 16428, DENVER, CO, 80216
|Every effort has been made to ensure the accuracy of the Clostridium Perfringens Types C&D Toxoid information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the US product label or package insert.|
Copyright © 2018 Animalytix LLC. Updated: 2018-11-30